Testing effectiveness (Phase 2)Active Not RecruitingNCT05768711
What this trial is testing
Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR)
Who this might be right for
Chronic Myeloid Leukemia
Groupe Francophone des Myelodysplasies 44